Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis. [electronic resource]
Producer: 20120113Description: 1111-9 p. digitalISSN:- 1435-5922
- Adult
- Aged
- Anemia, Hemolytic -- chemically induced
- Antiviral Agents -- administration & dosage
- Cohort Studies
- Decision Trees
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Reproducibility of Results
- Retrospective Studies
- Ribavirin -- administration & dosage
- Severity of Illness Index
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.